91
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Role of maternal serum interleukin 17 in preeclampsia: diagnosis and prognosis

ORCID Icon, , &
Pages 175-180 | Published online: 11 Jul 2019

References

  • Alsamarai AGM, Majeed HM, Alobaidi AH. Interleukin-6 (Il-6), interleukin-17 (Il-17) and angiopoietin in women with bad obstetric history Kirkuk, Iraq. Am Res J Haematol. 2016;1:1–11.
  • Darmochwal-Kolarz D, Michalak M, Kolarz B, et al. The role of interleukin-17, interleukin-23, and transforming growth factor in pregnancy complicated by placental insufficiency. Biomed Res Int. 2017;1:1–5. Article ID 6904325.
  • Molvarec A, Ito M, Shima T, et al. Decreased proportion of peripheral blood vascular endothelial growth factor expressing T and natural killer cells in preeclampsia. Am J Obstet Gynecol. 2010;203(567):e561–e568. doi:10.1016/j.ajog.2010.07.019
  • Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63:601–610. doi:10.1111/j.1600-0897.2010.00852.x20455873
  • Michel ML, Keller AC, Paget C, et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med. 2007;204:995–1001. doi:10.1084/jem.2006155117470641
  • Molvarec A, Czegle I, Szij´Art´O J, Rigó J. Increased circulating interleukin-17 levels in preeclampsia. J Reprod Immunol. 2015;112:53–57. doi:10.1016/j.jri.2015.05.00726232149
  • Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigo J. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with preeclampsia. Hypertens Res. 2010;33:892–898. doi:10.1038/hr.2010.9220535121
  • National Collaborating Centre for Women’s and Children’s Health (UK) Hypertension in Pregnancy. The Management of Hypertensive Disorders during Pregnancy. London, UK: RCOG Press; 2010.
  • Martínez-García EA, Chávez-Robles B, Sánchez-Hernández PE, et al. IL-17 increased in the third trimester healthy women with term labor. Am J Reprod Immunol. 2011;65(2):99–103. doi:10.1111/j.1600-0897.2010.00893.x20618180
  • Wang H, Guo M, Liu F, et al. Role of IL-17 variants in preeclampsia in Chinese Han Women. PLoS One. 2015;10(10):e0140118. doi:10.1371/journal.pone.014011826451724
  • Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. Plasma IL-17, IL-35, interferon-Y, SOCS3 and TGF- B levels in pregnant women with preeclampsia and their relation with severity of disease. J Maternal Fetal Neonatal Med. 2014;27(15):1513–1517. doi:10.3109/14767058.2013.861415
  • Poordast T, Najib FS, Baharlou R, Bijani A, Alamdarloo SM, Poordast A. Assessment of T helper 17-associated cytokines in third trimester of pregnancy. Iran J Immunol. 2017;14(2):172–179.28630387
  • Foroozanfard F, Soleimani A, Arbab E, Samimi M, Tamadon MR. Relationship between IL-17 and ambulatory blood pressure in polycystic ovary syndrome. Nephropathol. 2017;6(1):15–24. doi:10.15171/jnp.2017.04
  • Chen Q, Zhao M, Guo F, et al. The reduction of circulating levels of IL-6 in pregnant women with preeclampsia by magnesium sulphate and nifedipine: in vitro evidence for potential mechanisms. Placenta. 2015;36(6):661–666. doi:10.1016/j.placenta.2015.03.00925907222
  • Sugimoto J, Romani AM, Valentin-Torres AM, et al. Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol. 2012;188(12). doi:10.4049/jimmunol.1101765